当前位置：
X-MOL 学术
›
J. Adv. Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
LTX-315 is a novel broad-spectrum antimicrobial peptide against clinical multidrug-resistant bacteria
Journal of Advanced Research ( IF 11.4 ) Pub Date : 2025-01-09 , DOI: 10.1016/j.jare.2024.12.044
Yang Tang, Chen Yang, Jiamin Zhao, Heng Heng, Mingxiu Peng, Liang Sun, Liang Dai, Edward Wai-Chi Chan, Sheng Chen
Journal of Advanced Research ( IF 11.4 ) Pub Date : 2025-01-09 , DOI: 10.1016/j.jare.2024.12.044
Yang Tang, Chen Yang, Jiamin Zhao, Heng Heng, Mingxiu Peng, Liang Sun, Liang Dai, Edward Wai-Chi Chan, Sheng Chen
|
Infections stemming from multidrug-resistant bacteria present a substantial threat to public health today. Discovering or synthesizing novel compounds is crucial to alleviate this pressing situation.
中文翻译：
LTX-315 是一种针对临床多重耐药菌的新型广谱抗菌肽
由多重耐药细菌引起的感染对当今的公共卫生构成了重大威胁。发现或合成新化合物对于缓解这种紧迫的情况至关重要。
更新日期：2025-01-09
中文翻译：
LTX-315 是一种针对临床多重耐药菌的新型广谱抗菌肽
由多重耐药细菌引起的感染对当今的公共卫生构成了重大威胁。发现或合成新化合物对于缓解这种紧迫的情况至关重要。
京公网安备 11010802027423号